Moderna and Merck's Cancer Vaccine Delivers a Smackdown

The Rock's here to electrify your day! Moderna and Merck just threw down a major victory with their personalized mRNA cancer vaccine, showing it can keep melanoma from making a comeback in high-risk patients. With 1,137 gladiators in the arena, this Phase 3 trial is flexing alongside Keytruda, and the cancer vaccine showdown is heating up!